Harmony’s Next-Gen Narcolepsy Drug Advances With Surprising New Results
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) recently reported encouraging data from its pivotal bioequivalence study for pitolisant gastro-resistant (GR), marking a major milestone as the company …
Harmony’s Next-Gen Narcolepsy Drug Advances With Surprising New Results Read More